Jan 5, 2024
January 26, 2025
This week’s newsletter included:
- Participate in Life Sciences Day on Capitol Hill
- Utah Track from the 2023 Utah Life Sciences Summit
- Headed to J.P. Morgan
- Co-Diagnostics Completes Submission to FDA for Co-Dx PCR Pro
- PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation
- Canyon Labs: Senior Leadership Changes
- BlueWind Medical Brings Revi Implantable Tibial Neuromodulation Device to Patients
- Bench to Bedside Mentor Mixer & CMI Open-House
- Utah Ranked as the Best State for Economic Mobility
- Utah Ranks #5 in 2023 Best States for Manufacturing
- Utah Business: Is Silicon Valley Bank Back? Here’s How the Bank Is Rebuilding in Utah
- IMA Issues Life Sciences Industry Report
- Nasdaq Spotlights Myriad Genetics’ New CFO, Scott Leffler
- Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Featured New Member: Eris Biotech
Recent News
- Improving Women’s Health: MobileODT Joins Liger Medical
- Wasatch Health Announces Structured Capital Fund
- Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains
- Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial
- Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
